Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Badyal, Ruchi Kiran
Saxena, Ajay Kumar
Pandey, Kailash C
MetadataShow full item record
AbstractBoth designed MEVs are composed of CTL and HTL epitopes screened from 11 Open Reading Frame (ORF), structural and nonstructural proteins of the SARS-CoV-2 proteome. Both MEVs also carry potential B-cell linear and discontinuous epitopes as well as interferon gamma-inducing epitopes. To enhance the immune response of our vaccine design, truncated (residues 10-153) Onchocerca volvulus activation-associated secreted protein-1 was used as an adjuvant at the N termini of both MEVs. The tertiary models for both the designed MEVs were generated, refined, and further analyzed for stable molecular interaction with toll-like receptor 3. Codon-biased complementary DNA (cDNA) was generated for both MEVs and analyzed in silico for high level expression in a mammalian (human) host cell line.
CitationJMIR Bioinform Biotech. 2020 Jun 19;1(1):e19371. doi: 10.2196/19371.
AffiliationCSSB, Centre for Structural Systembiologie, Notkestr.85, 22607 Hamburg. Germany.
Publisher: JMIR Publications Inc.
The following license files are associated with this item:
- Creative Commons
- Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach.
- Authors: Srivastava S, Kamthania M, Singh S, Saxena AK, Sharma N
- Issue date: 2018
- Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics.
- Authors: Srivastava S, Kamthania M, Kumar Pandey R, Kumar Saxena A, Saxena V, Kumar Singh S, Kumar Sharma R, Sharma N
- Issue date: 2019 Oct
- Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
- Authors: Srivastava S, Verma S, Kamthania M, Saxena AK, Pandey KC, Pande V, Kolbe M
- Issue date: 2023
- Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
- Authors: Tahir Ul Qamar M, Shahid F, Aslam S, Ashfaq UA, Aslam S, Fatima I, Fareed MM, Zohaib A, Chen LL
- Issue date: 2020 Sep 16
- Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
- Authors: Srivastava S, Verma S, Kamthania M, Agarwal D, Saxena AK, Kolbe M, Singh S, Kotnis A, Rathi B, Nayar SA, Shin HJ, Vashisht K, Pandey KC
- Issue date: 2022 Mar